Health Care Fraud Unit Secures Result in Landmark Case
Read Press ReleaseHealth Care Fraud Unit Secures Result in Landmark Case
Read Press ReleaseHome
DEA to Temporarily Schedule 7-OH and Related Substances to Protect Public Safety
WASHINGTON – Today, the U.S. Drug Enforcement Administration filed its intent to temporarily place 7-hydroxymitagynine (7-OH) and three related substances into Schedule I of the Controlled Substances Act (CSA). Prior to DEA issuing this notice, the Department of Health and Human Services (HHS) confirmed synthetic 7-OH, and the three related substances have no accepted medical use and a high potential for abuse.
DEA Announces Interested Parties for Upcoming Marijuana Rescheduling Hearing
The hearing on the NPRM is scheduled to commence on June 29, 2026, at 9:00 a.m. ET and conclude not later than July 15, 2026.
About the DEA
The mission of the Drug Enforcement Administration (DEA) is to ensure the safety and health of American communities by combating criminal drug networks bringing harm, violence, overdoses, and poisonings to the United States. To accomplish this mission, the DEA employs approximately 10,000 personnel throughout the world – Special Agents, Diversion Investigators, Intelligence Analysts, Chemists, and professional staff – across 241 domestic offices in 23 Divisions and 93 foreign offices across the globe.
Featured Resources
Featured Resources
Recent News Releases
PRESS RELEASE
Orlando Pharmacy and Pharmacist Agree to Pay $50,000 to Settle Controlled Substances Act Violations
July 09, 2026
PRESS RELEASE
Two Seattle Area Men Charged with String of Pharmacy Burglaries Throughout the Puget Sound Region
July 08, 2026
Community Outreach
Community Outreach
Most Wanted Fugitives
DEA publishes a list of the most wanted fugitives wanted for alleged federal violations of controlled substances laws to help capture and bring them to justice.
DEA on Instagram
View this profile on InstagramDEA-Drug Enforcement Admin. (@deahq) • Instagram photos and videos